Tag: investments

The global exosome research market is anticipated to expand from USD 214.4 million in 2025 to USD 480.6 million by 2030, at a CAGR of 17.5%. This growth is driven by the rising need for advanced diagnostics due to the prevalence of chronic diseases like cancer and neurodegenerative disorders. Exosomes, serving as biomarkers and therapeutic delivery agents, fulfill this demand. The kits & reagents segment is expected to lead growth, aligning with the increased demand for efficient exosome research tools. North America is projected to experience the highest growth, thanks to significant government investments supporting research initiatives. Key players such as Thermo Fisher Scientific and Bio-Techne are profiled.

AB Akola Group, an investment company that owns one of the largest agricultural and food production groups in the Baltic States, has temporarily postponed the construction of a biomethane gas production plant in the Kaišiadorys district through its indirectly controlled company AB Kaišiadorių paukštynas. This investment project remains part of AB Akola Group's long-term development plans.

(Fornebu, Norway – 18 July 2025) Telenor Group delivers very strong results in the second quarter of 2025, triggering a raised EBITDA outlook for both the Nordics and Group. At the same time the company solidifies its position in the Nordic fibre market with a NOK 1.4 billion multi-year investment in Finland and the recently announced NOK 6 billion acquisition of GlobalConnect’s consumer business in Norway.

The Board of Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”) approved unaudited Telia Lietuva, AB Interim Financial Statements, prepared according to International Financial Reporting Standards as adopted by the European Union, for 6 months’ period ended 30 June 2025.

Second quarter 2025 operational update 

Over $500.0 Million in New Commitments This Week Alone

Half-year results – Neuilly-sur-Seine, Thursday July 17, 2025 – 5.45 pm